Insights on U.S. Prescription Drug Pricing Dynamics with Research Expert
Explore expert analysis on the factors affecting prescription drug prices in the U.S., including regulatory, market, and insurance dynamics shaping pharmaceutical costs.
US Drug Pricing Negotiations, Telehealth Flexibilities, 340B Pilot, and ACA Subsidies Update
Explore recent US developments on federal drug price negotiation expansion to commercial plans, DEA telehealth prescribing extensions, the 340B rebate pilot launch, and ACA subsidy debates in the Senate impacting insurance and healthcare markets.
Medicare Drug Price Negotiations Expand to 15 More Medications in 2027
CMS expands Medicare drug price negotiations to 15 more medications starting in 2027, including popular diabetes and weight loss treatments, aiming to reduce prescription costs and save Medicare billions.
Vermont Hospitals’ High Drug Markups Spark Calls for Systemic Health Care Reform
Vermont hospitals face scrutiny for high outpatient drug markups driving health insurance costs. Lawmakers consider drug price caps amid calls for systemic health care financing reforms.